Prophylaxis with a Respiratory Syncytial Virus (RSV) Anti-G Protein Monoclonal Antibody Shifts the Adaptive Immune Response to RSV rA2-line19F Infection from Th2 to Th1 in BALB/c Mice

Respiratory syncytial virus (RSV) is the single most important cause of serious lower respiratory tract infections in young children, yet no highly effective treatment or vaccine is available. In the present study, we investigated the effect of prophylactic treatment with the intact and F(ab′)(2) fo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Boyoglu-Barnum, Seyhan, Chirkova, Tatiana, Todd, Sean O., Barnum, Thomas R., Gaston, Kelsey A., Jorquera, Patricia, Haynes, Lia M., Tripp, Ralph A., Moore, Martin L., Anderson, Larry J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2014
Konular:
Vaccines and Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4178873/
https://ncbi.nlm.nih.gov/pubmed/24990999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01503-14
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller